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Abstract
Background: Locally advanced colorectal cancers form a distinct subgroup where contiguous
organs could be involved without distant metastases and so may be amenable to curative surgical
resection. It was our objective to report our experience in treating six such patients with operable
locally advanced colorectal carcinomas.
Methods: We retrospectively reviewed the case notes of 47 patients who were diagnosed with
colorectal cancers at M S Ramaiah Medical Teaching Hospital between the years 1996 – 2001. Six
patients were identified with T4 lesions, adjacent organ involvement and with no nodal
involvement. The treatments and outcomes for these patients were then reviewed.
Results: Two of three patients with rectal malignancies who underwent pelvic exenteration
succumbed to disease recurrence within the first 18 months. One of the three patients with colonic
cancers died of non malignant causes. The other two are disease free till date.
Conclusions: Aggressive multivisceral resections for locally advanced colonic cancers might be
appropriate. Rectal cancers when locally advanced may be considered for pelvic exenteration, but
a more guarded prognosis may apply.
Background
Locally advanced colorectal tumors constitutes to about 5
– 22% of all colorectal cancers at the time of presentation
[1]. This type of tumor forms a distinct sub class of color-
ectal tumors characterized by aggressive local behavior in
the form of invasion of adjacent organs or structures with
somewhat surprisingly no distant metastasis at presenta-
tion. The survivals of such cases that undergo multivis-
ceral resections are 58% and 43% for UICC stage II and III
respectively. These results are similar to those undergoing
conventional resections [1]. In addition, there is a sugges-
tion of elevated stage related late results to the same level
as that associated with tumors where there is no direct
invasion of contiguous organs [1]. Addressing the local
disease adequately with multi-visceral resections when
necessary could result in favorable out come. However en-
bloc surgical resection of the tumor forms a surgical chal-
lenge and the risks of complications and death must be
weighed against probable survival benefits. The post oper-
ative complication rate of multivisceral resection is about
11.5%; 30 day operative mortality is 3.6% and compares
favorably with non-multivisceral resections [1]. It was our
objective to report our experience in treating six such
patients with operable locally advanced colorectal
carcinomas.
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Methods
During the years 1996–2001, 47 patients with colorectal
cancers were treated at our institute. All patients under-
went a rectal exam, punch biopsy if it were an accessible
rectal lesion or colonoscopy and biopsy if it were a colonic
lesion. Screening colonoscopy for a synchronous lesion
was however done for all patients. Patients in whom a
biopsy confirmed a malignant lesion underwent an ultra-
sound (US) study of the abdomen, chest X-ray and Car-
cino-embryonic antigen (CEA) estimation. Patients with
doubtful involvement of adjacent organs or structures
underwent CT scan. Cystoscopy was performed when uri-
nary bladder involvement was suspected on CT scan.
Patients were diagnosed as locally advanced when the
staging evaluation showed involvement of adjacent organ
or structure. Though nodal evaluation is suboptimal with
US or CT scan, all patients with 'N0' status on these inves-
tigations were included as locally advanced while those
with 'N+' on evaluation were excluded. Patients with
metastasis to any organ were excluded. The preoperative
staging of the tumor was T4, N0, M0. Elective surgery was
performed on all cases. No pre-operative therapy was
administered. All patients were administered adjuvant
radiation and chemotherapy which was instituted imme-
diately after wound healing (between 16 and 29 days post
surgery). A total dose of 5000 centi-Gray of external beam
radiation in combination with chemotherapy consisting
of 5-Fluoro-Uracil (5-FU) and leucovorin was adminis-
tered. The dose of 5-FU was 425 mg/m2 and that of leu-
covorin 20 mg/m2. This combination was administered as
infusion on day 1 to 5, and six such cycles every 28 days
were instituted as part of chemotherapy regimen. The
therapy in colonic carcinoma was sequenced as 1 cycle of
chemotherapy followed by radiation and the remaining 5
cycles after completion of radiation. In case of rectal can-
cers, the chemotherapy was administered concurrently
with radiation. The administration of leucovorin was
with-held during radiation and instead, the dose of 5-FU
was increased to 500 mg/m2. Follow up was by clinical
examination every 3 months for first two years, and six
monthly until 5 years. The evaluation included alternate
year CT scan, annual US abdomen, chest X-ray, colonos-
copy and CEA levels every six months.
The two live patients have given consent for publication.
Consents have been obtained from the legal heirs of the
remaining four patients.
Results
The study group consisted of six patients (29 to 70 years),
three of whom had locally advanced colonic disease and
three of whom had locally advanced rectal disease. Pre
operative CEA levels were surprisingly within normal lim-
its in all six patients. The pre operative colonoscopic or
rectal biopsy had determined adenocarcinoma in all six
patients (Grade as shown in Table 1). In two of the
patients with rectal disease where involvement of the
bladder wall was suspected, cystoscopic findings were
normal. All the patients were offered radical surgery on
elective basis. The radicality included removal of adjacent
involved organs which could increase the complication
rate of extensive surgery. In addition such extended resec-
tions for rectal cancer would result in exenterative pelvic
surgery resulting in abdominal stomas. Surgical resection
margins were negative in all cases.
Case 1
Patient presented with a 2 month history of abdominal
mass. There was no history of weight loss or altered bowel
habits. The mass was firm with irregular borders and
restricted mobility. CT scan of abdomen revealed a large
mass lesion arising from the caecum and ascending colon
apparently infiltrating the anterior abdominal wall (Fig
1). Patient underwent a radical right hemicolectomy with
en-bloc resection of involved abdominal wall (Fig 2). The
right branch of the middle colic, the right colic and ileo-
colic vessels were ligated at the origin. Retroperitoneum
was not involved. A two layer hand sewn ileocolic anasto-
mosis was performed. The abdominal wall muscles were
resected with a 2.5 cm margin and the resultant defect was
repaired with a polypropylene mesh. The patient received
adjuvant radiation and chemotherapy as described above
and is disease free 3 1/2 years after surgery.
Case 2
Patient presented with a 6 month history of bleeding per
rectum. There was no history of weight loss. Patient's
hemoglobin was 10.2 gms / dl. Patient had ignored the
complaint for 3 months but even at a later date was unfor-
tunately not advised to undergo sigmoidoscopy where he
was evaluated. Patient underwent colonoscopic evalua-
tion at our institute after evaluation. CT scan showed pos-
sible involvement of abdominal wall with the growth
arising from sigmoid colon. Intra-operatively, the mass
was found to involve the posterior rectus sheath. Sigmoid
colectomy was performed along with resection of the
involved posterior rectus sheath and the rectus muscle en-
bloc. Splenic flexure was mobilized to obtain colorectal
hand sewn anastomosis. Primary closure of the rectus
defect was achieved and patient received adjuvant radia-
tion and chemotherapy. The patient is disease free 3 years
post surgery.
Case 3
Patient was diabetic, asymptomatic; ultrasound per-
formed for evaluation of kidneys for diabetic nephropa-
thy incidentally detected the mass lesion in sigmoid
colon. Biopsy specimen was obtained at colonoscopy; no
synchronous lesion was detected in the rest of the colon.
CT scan revealed close relation of the sigmoid mass lesionInternational Seminars in Surgical Oncology 2004, 1:8 http://www.issoonline.com/content/1/1/8
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to the bladder dome but was unable to comment categor-
ically on wall infiltration. Urinary bladder mucosa was
intact and normal on pre-operative cystoscopy. Intra-
operatively, the lesion was found adherent to bladder
dome. Sigmoid colectomy and part of the bladder wall
was resected en-bloc. There was no pathologic evidence of
bladder involvement. Patient had ishcaemic heart disease
and diabetic nephropathy; she later developed
myocardial infarction and renal failure while on adjuvant
therapy 7 months post surgery and succumbed to the
same.
Case 4
Patient had bleeding per rectum and constipation for 18
months. Patient was evaluated and treated as
hemorrhoids initially (no surgical intervention). About 6
months prior to presentation at our institute, he was diag-
nosed as rectal cancer and was advised abdomino-peri-
neal resection. Patient was scared of surgery and waited
without any therapy. Rest of the large bowel was normal
on colonoscopy. A CT scan showed involvement of the
urinary bladder and prostate by a rectal mass while bony
pelvis appeared free of tumor involvement. The patient
underwent a total pelvic exenteration with formation of a
urinary diversion by ileal conduit. After a lower midline
laparotomy, abdomen was evaluated for any ascites or
liver metastasis. Para-aortic area was palpated and rest of
peritoneal cavity was evaluated for any metastatic deposit.
Inferior mesenteric artery was ligated beyond the origin of
the left colic artery. Bilateral pelvic nodal dissection was
completed. Sigmoid colon and rectum was mobilized as
in abdominoperineal resection over the sacral hollow.
Anteriorly the dissection was carried out in the retropubic
space to access the urethra beyond the prostate. Lateral
dissection was carried out which included the ligation of
the superior vesical vessels. Both the ureters were ligated
below the pelvic brim in the true pelvis at least 3 cm prox-
imal to palpable disease. Isolated loop of ileum was
mobilized based on two vessels. One end of the loop was
closed and both ureters were anastomosed separately to
the loop. Intestinal continuity was obtained with ileo-ileal
end to end anastomosis. This ileal loop was brought out
as a urinary stoma on the right side and the cut colon was
brought out as colostomy on the left side. The patient's
postoperative recovery was unremarkable except for a
uereteric leak which settled by 10th post operative day.
Patient received adjuvant therapy but was irregular on fol-
low-up and refused to be investigated. Patient developed
hepatic metastasis and succumbed to the disease after 18
months.
Table 1: Salient Clinico – pathologic features of locally advanced colorectal carcinomas
Site of 
malignancy
Age Sex Pathologic 
'T' Status




PNS ‡ PN/PV § 
spread
Colon 56 Male T 4 II - + (abdominal wall) N0 - -
58 Male T4 II - + (abdominal wall) N0 - +
67 Female T3 II - - (bladder dome) N0 - -
Rectum 45 Male T4 I + + (bladder / prostate) N1 + +
27 Female T4 I + + (uterus and vagina) N2 + +
69 Male T4 II + + (bladder / prostate) N2 + +
* Mucinous or signet ring carcinoma
† Pathologic involvement of adjacent organ
‡ Perinodal spread
§ Perineural / perivascular spread
CT scan of the abdomen showing the involvement of abdom- inal wall muscles and adhesions to neighboring intestines Figure 1
CT scan of the abdomen showing the involvement of abdom-
inal wall muscles and adhesions to neighboring intestines.International Seminars in Surgical Oncology 2004, 1:8 http://www.issoonline.com/content/1/1/8
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Case 5
Patient had bleeding per rectum and constipation for 4
months. Patient had significant weight loss over previous
2 months. Patient had circumferential rectal carcinoma
involving uterus and upper part of vagina. Rectal carci-
noma was proved by biopsy. Rest of the colon was normal
on colonoscopy. Upper vaginal mucosa was intact but
indurated underneath. CT scan showed infiltration of
lower part of uterus and upper vagina. Patient underwent
posterior pelvic exenteration. Uterus, including both the
fallopian tubes and ovaries were removed en-bloc along
with vagina and rectum. Surgery was followed by adjuvant
radiation and chemotherapy. Patient succumbed to the
disease 1 year later with multiple metastases in liver, brain
and malignant ascites.
Case 6
Patient had bleeding per rectum and constipation for 3
months. A preoperative CT scan with rectal and intrave-
nous contrast revealed involvement of prostate and possi-
bly bladder. Colonoscopy did not reveal any other lesion.
He underwent a total pelvic exenteration (Fig 3) with ileal
conduit similar to case 4. Patient developed fever 48 hours
after surgery. Evaluation for infective pathology including
cultures from catheters and venous access tips did not
reveal any source of infection. There was no pocket of
collection on repeated abdominal ultrasound. There was
Specimen of radical right hemicolectomy with en-bloc resection of abdominal wall muscle (indicated by small arrow) and neigh- boring small intestines (indicated by dotted arrows) Figure 2
Specimen of radical right hemicolectomy with en-bloc resection of abdominal wall muscle (indicated by small arrow) and neigh-
boring small intestines (indicated by dotted arrows).International Seminars in Surgical Oncology 2004, 1:8 http://www.issoonline.com/content/1/1/8
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raised leukocyte count. A possibility of sepsis from an
occult focus was considered and treated. However, on the
5th post operative day, patient developed vomiting and
had raised serum creatinine values. Values of fibrin degra-
dation products were also raised and a diagnosis of dis-
seminated intravascular coagulation and renal failure was
entertained. Patient had prolonged prothrombin time but
did not have any clinical bleed. He died on 30th day post
operative while on recovery from the same. The post sur-
gical pathology reports are summarized in Table 1.
Discussion
Surgical resection remains the primary and most effective
treatment for advanced colorectal cancers [2]. The 5-year
survival rate of the overall group of patients undergoing
multivisceral resection is 42%, that of the subgroup
undergoing curative surgery is 51%, and that of the sub-
group receiving only palliative resection is 0% [1]. In the
presence of local tumor extension the distinction between
inflammatory adherence and malignant invasion is
impossible to make intra operatively. Adherence of the
neoplasm to surrounding structures demonstrates patho-
logical tumor invasion in approximately 50% of cases
[1,2]. The operative intent of the surgeon should be to
achieve complete extirpation with adequate margins in
the involved structures. Dissection between malignancy
and adherent structures, or biopsy and frozen section is
not recommended as these procedures may promote
tumor dissemination [1,2], which may have a detrimental
impact on prognosis [3-5]. The concept of en-bloc resec-
Specimen of pelvic exenteration with cut open rectum showing the rectal adenocarcinoma infiltrating the prostate Figure 3
Specimen of pelvic exenteration with cut open rectum showing the rectal adenocarcinoma infiltrating the prostate. Foley's 
catheter is also seen.International Seminars in Surgical Oncology 2004, 1:8 http://www.issoonline.com/content/1/1/8
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tion has significantly reduced the local recurrence rate
from 77% to 36% and significantly improved the 5 year
over all survival of 43% [1,4-6]. Other studies have also
shown improved survival of similar staged colorectal can-
cers with en-bloc resection [7,8]. The survivals reported in
various studies are shown in Table 2[1,2,4,9-11]. The 5-
year survivals are comparable ranging from 38% to 52%.
Although colon and rectal cancers which required multi-
visceral resections are shown separately, the survivals are
not indicated differently. For similar 'T' status, the corre-
sponding 'N+' status of colon versus rectum has not been
studied. Our present study is small but the overall survival
is 33% and compares with larger studies. In addition,
since a very high percentage of even large T4 tumors have
not yet metastasized to the regional lymph nodes, a mul-
tivisceral resection offers the chance to radically remove
the local disease and affect a cure [1,12]. All patients in
our study group underwent en-bloc resection. No attempt
was made to separate the adherent structure to confirm or
negate the involvement of adjacent organ per operatively.
Since colon spans the entire periphery of the abdomen,
almost all the abdominal organs have been reported to be
involved [2]. Multivisceral resections have been recom-
mended whenever necessary as it could offer cure or at
least significant palliation [13-15]. En-bloc resections
have been recommended even when it warrants a pancre-
atico-duodencetomy [16,17]. In the present report, the
en-bloc resections included abdominal wall in two cases
and urinary bladder in one.
Rectum cancers involve the pelvic genital organs and or
urinary bladder anteriorly. Posteriorly it could involve the
sacrum. Exenterative pelvic surgeries are warranted for
locally advanced rectal cancers [18]. Pelvic exenteration
and sacral resection for primary or recurrent rectal cancer
are tolerable procedures with a low mortality rate [19].
Although they provide a survival benefit if curative resec-
tion is possible, the associated morbidity remains high
[19-21]. The complications described include sepsis,
intra-abdominal abscess, pelvic abscess, enteric fistula,
enteric anastomotic leak, wound infection, ileoureteral
anastomotic leak, ileoureteral anastomotic stenosis,
bowel obstruction, vascular injury, bleed, liver dysfunc-
tion and pneumonia. In the present study, both the male
patients underwent total pelvic exenteration with ileal
conduit for urinary diversion. The female patient under-
went posterior pelvic exenteration. The male patient who
lived for 18 months did not have any major problem to
take care of both the stomas. Similar thoughts that a small
reduction in patient's quality of life due to urinary diver-
sion should not be a major contraindication when surgery
with urinary diversion is warranted to obtain curative
resection have been echoed [22].
Pre-operative nodal evaluation by abdominal CT scan,
MRI or endoscopic ultrasound may be inadequate.
Though endosonography can detect perirectal nodes, its
inability to reliably predict pathologic involvement is a
constraint [23]. Nodal status assessment is considered
adequate when at least 14 nodes are examined [24]. In
some studies, nodal metastasis has insignificantly altered
survival [4,6,25,26]. In contrast, other studies have shown
that presence of lymph node involvement is associated
with poor prognosis [21]. Studies have shown that 5 year
survival in patients with nodal metastasis was 0% to 11%,
significantly lower than the 37% to 76% survival rate in
their patients without nodal metastases [11,27,28]. These
studies have even cast doubts over usefulness of pelvic
exenteration in patients with nodal disease though some
would still recommend it [29]. None of the patients in the
study were evaluated by endosonography but were evalu-
ated by CT scan. Accepting that it is a poor tool for nodal
evaluation, pre-operative involvement was not detected in
any patient in the study group. Moreover, lymph node sta-
tus can be accurately determined by pathologic
examination only. Hence the investigations might not
contribute to decision making though cases with obvious
metastasis could be excluded from major resections. In
our series of six cases, all the colonic patients were node
negative and had no vascular invasion. With multi visceral
resections, T4 colonic cancers had acceptable morbidity
and better treatment outcome. However, rectal cancer
patients had poor prognostic factors like vascular inva-
sion, lymph nodal involvement and histological type of
Table 2: Summary of survival data from a few large studies
Author Multivisceral 
Resections
Colon Rectum Death Rate 5-year Survival 
Rate
Reiner (1987) 158 53 105 12% 38%
Heslov (1988) 58 26 32 5% 38%
Montesani (1991) 33 - - - 30%
Hermanek (1992) 197 119 78 3% 52%
Gebhardt (1999) 173 122 51 4% 51%
Lehnert (2002) 201 139 62 7.5% 51%International Seminars in Surgical Oncology 2004, 1:8 http://www.issoonline.com/content/1/1/8
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mucinous / signet ring variety. Another striking feature
was that though colonic cancers were grade II tumors, they
were pathologically N0. But rectal cancers were patholog-
ically N1, N2 and had perinodal spread despite being
grade I tumors.
Down staging of locally advanced rectal cancers have been
achieved with pre-operative radiation or chemotherapy or
both resulting in decreased recurrence and improved dis-
ease free survival [30-35]. The results of IORT hold some
promise [36,37]. It would be fair to say that there is still
no agreement as to the optimal sequencing of chemother-
apy, radiation, and definitive surgery in immediately
operable patients, and both preoperative and postopera-
tive approaches have vocal proponents [38]. In the
present study, pre-operative chemotherapy or radiation
was not administered to any patient. There have been no
studies to suggest that pre-operative chemoradiation
would decrease the magnitude of surgical resection and
hence a patient suitable for exenteration would still
require the same after such a therapy. In addition, admin-
istration of radiation pre-operatively increases the mor-
bidity after exenteration [39]. It must also be noted that
studies on pre-operative chemoradiation have shown
improvement is DFS and not in OS. Till such time there
are conclusive results in these areas for pre-operative ther-
apy with chemoradiation, such a therapy would continue
to be debated.
Although it could be inappropriate to draw conclusions
from a small number of cases, certain features require fur-
ther deliberation. T4 colonic cancers have had better out-
comes compared to T4 rectal cancers. Many of the earlier
reports have combined results of colonic and rectal can-
cers. In addition, the reports have combined locally
advanced and recurrent cancers. As the tumor biology of
these areas is different, the results of colon and rectum
have to be viewed separately. In addition, the morbidity
and mortality associated with multivisceral resections are
different of these areas. Since nodal metastasis were seen
in all T4 rectal cancers and in none of the colonic T4
cancers, it would be interesting to evaluate percentage of
nodal metastasis separately for colonic and rectal cancers
with similar T stages. Another indicator of aggressive biol-
ogy of rectal cancers compared to colonic cancers is the
fact that lower grade rectal cancers had more nodal metas-
tasis, perineural and perivascular invasion compared to
higher grade colon cancers.
Conclusions
Locally advanced colonic cancers are to be evaluated and
treated aggressively with multivisceral en-bloc resections.
The outcomes are likely to be favorable and hence the
results gratifying. Locally advanced rectal cancers require
exenterative pelvic surgery which carries higher morbidity
and mortality. In addition, rectal cancers are biologically
more aggressive. Hence exenterative pelvic surgeries are to
be done more selectively with guarded disease out come
for T4 rectal tumors. Future improvements in chemother-
apeutic agents and radiation techniques could make
down staging of these malignancies a reality not only in
terms of operability but in improving overall survival.





MRI: Magnetic Resonance Imaging
IORT: Intraoperative Radiotherapy
DFS: Disease free survival
OS: Overall survival
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